BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, Aguinaga L, Berger RD, Cuesta A, Daubert JP, Dubner S, Ellenbogen KA, Estes NA 3rd, Fenelon G, Garcia FC, Gasparini M, Haines DE, Healey JS, Hurtwitz JL, Keegan R, Kolb C, Kuck KH, Marinskis G, Martinelli M, McGuire M, Molina LG, Okumura K, Proclemer A, Russo AM, Singh JP, Swerdlow CD, Teo WS, Uribe W, Viskin S, Wang CC, Zhang S. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. J Arrhythm 2016;32:1-28. [PMID: 26949427 DOI: 10.1016/j.joa.2015.12.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Bozyel S, Aktas M, Mutluer FO, Guler TE, Dervis E, Argan O, Celikyurt U, Agir A, Vural A. Reprogramming the tachycardia parameters with long-detection strategy in patients with pre-existing implantable cardioverter-defibrillator. Acta Cardiol 2019;74:246-51. [PMID: 30058473 DOI: 10.1080/00015385.2018.1488664] [Reference Citation Analysis]
2 Kuschyk J, Müller-Leisse J, Duncker D, Tülümen E, Fastenrath F, Fastner C, Kruska M, Akin I, Liebe V, Borggrefe M, Veltmann C, Rudic B. Comparison of transvenous vs subcutaneous defibrillator therapy in patients with cardiac arrhythmia syndromes and genetic cardiomyopathies. Int J Cardiol 2021;323:100-5. [PMID: 32871189 DOI: 10.1016/j.ijcard.2020.08.089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Frydensberg VS, Johansen JB, Möller S, Riahi S, Wehberg S, Haarbo J, Philbert BT, Jørgensen OD, Larsen ML, Nielsen JC, Pedersen SS. Anxiety and depression symptoms in Danish patients with an implantable cardioverter-defibrillator: prevalence and association with indication and sex up to 2 years of follow-up (data from the national DEFIB-WOMEN study). Europace 2020;22:1830-40. [PMID: 33106878 DOI: 10.1093/europace/euaa176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Kindermann I, Wedegärtner SM, Bernhard B, Ukena J, Lenski D, Karbach J, Schwantke I, Ukena C, Böhm M. Changes in quality of life, depression, general anxiety, and heart-focused anxiety after defibrillator implantation. ESC Heart Fail 2021;8:2502-12. [PMID: 34047078 DOI: 10.1002/ehf2.13416] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Cao M, Stolen CM, Ahmed R, Schloss EJ, Lobban JH, Kwan B, Varma N, Boehmer JP. Small decreases in biventricular pacing percentages are associated with multiple metrics of worsening heart failure as measured from a cardiac resynchronization therapy defibrillator. Int J Cardiol 2021;335:73-9. [PMID: 33812951 DOI: 10.1016/j.ijcard.2021.03.073] [Reference Citation Analysis]
6 Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Circulation. 2018;138:e272-e391. [PMID: 29084731 DOI: 10.1161/cir.0000000000000549] [Cited by in Crossref: 84] [Cited by in F6Publishing: 94] [Article Influence: 28.0] [Reference Citation Analysis]
7 Naka KK, Bazoukis G, Bechlioulis A, Korantzopoulos P, Michalis LK, Ntzani EE. Association between atrial fibrillation and patient-important outcomes in heart failure patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis. Eur Heart J Qual Care Clin Outcomes 2019;5:96-104. [PMID: 30462233 DOI: 10.1093/ehjqcco/qcy054] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Almehmadi F, Porta-Sánchez A, Ha ACT, Fischer HD, Wang X, Austin PC, Lee DS, Nanthakumar K. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry. J Am Heart Assoc 2017;6:e006220. [PMID: 28862957 DOI: 10.1161/JAHA.117.006220] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 3.8] [Reference Citation Analysis]
9 Al-atia B, Vandenberk B, Vörös G, Garweg C, Ector J, Willems R. Predictors of a high defibrillation threshold test during routine ICD implantation. Acta Cardiologica 2017;73:267-73. [DOI: 10.1080/00015385.2017.1371455] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 van Dijk VF, Boersma LV. The subcutaneous implantable cardioverter defibrillator in 2019 and beyond. Trends in Cardiovascular Medicine 2020;30:378-84. [DOI: 10.1016/j.tcm.2019.09.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2017;pii:CIR.0000000000000548. [PMID: 29084733 DOI: 10.1161/cir.0000000000000548] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 16.3] [Reference Citation Analysis]
12 Lillo-Castellano JM, Marina-Breysse M, Gómez-Gallanti A, Martínez-Ferrer JB, Alzueta J, Pérez-Álvarez L, Alberola A, Fernández-Lozano I, Rodríguez A, Porro R, Anguera I, Fontenla A, González-Ferrer JJ, Cañadas-Godoy V, Pérez-Castellano N, Garófalo D, Salvador-Montañés Ó, Calvo CJ, Quintanilla JG, Peinado R, Mora-Jiménez I, Pérez-Villacastín J, Rojo-Álvarez JL, Filgueiras-Rama D. Safety threshold of R-wave amplitudes in patients with implantable cardioverter defibrillator. Heart 2016;102:1662-70. [PMID: 27296239 DOI: 10.1136/heartjnl-2016-309295] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
13 Manolis AS, Manolis AA, Manolis TA, Melita H. Electrocardiography of cardiac resynchronization therapy: Pitfalls and practical tips. J Cardiovasc Electrophysiol 2021. [PMID: 34664758 DOI: 10.1111/jce.15267] [Reference Citation Analysis]
14 Ishibashi K, Noda T, Kamakura T, Wada M, Inoue Y, Okamura H, Kusano K. Importance of exercise testing shortly after subcutaneous implantable cardioverter-defibrillator implantation in patients with Brugada syndrome - The first case of associated inappropriate shock in Japan. J Arrhythm 2017;33:156-8. [PMID: 28416987 DOI: 10.1016/j.joa.2016.07.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
15 Baalman SWE, Quast ABE, Brouwer TF, Knops RE. An Overview of Clinical Outcomes in Transvenous and Subcutaneous ICD Patients. Curr Cardiol Rep 2018;20:72. [PMID: 29992422 DOI: 10.1007/s11886-018-1021-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
16 Pedersen SS, Andersen CM, Denollet J, Habibovic M. Depressive symptoms in patients with an implantable cardioverter defibrillator: Does treatment expectations play a role? Gen Hosp Psychiatry 2018;51:10-4. [PMID: 29268165 DOI: 10.1016/j.genhosppsych.2017.12.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Fang Y, Gu K, Yang B, Ju W, Chen H, Li M, Liu H, Wang J, Yang G, Chen M. What factors lead to the acceleration of ventricular tachycardia during antitachycardia pacing?-Results from over 1000 episodes. J Arrhythm 2018;34:36-45. [PMID: 29721112 DOI: 10.1002/joa3.12010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Suryanarayana P, Garza HK, Klewer J, Hutchinson MD. Electrophysiologic Considerations After Sudden Cardiac Arrest. Curr Cardiol Rev 2018;14:102-8. [PMID: 29737257 DOI: 10.2174/1573403X14666180507164443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]